WHO recommendations for misoprostol use for obstetric and gynecologic indications.
about
Misoprostol for Labour Induction after Previous Caesarean Section – Forever a “No Go”?Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysisPractice variation in the management of first trimester miscarriage in the Netherlands: a nationwide survey.Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion.Labour induction with prostaglandins: a systematic review and network meta-analysis.Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.Misoprostol use in medical evacuation of spontaneous miscarriage: Pilot drug use evaluation study at the Women's Hospital in QatarComparative study of titrated oral misoprostol solution and vaginal dinoprostone for labor induction at term pregnancyInduction of Labor in Post-Term Nulliparous and Parous Women - Potential Advantages of Misoprostol over DinoprostoneBalancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour.The state of routine and emergency obstetric and neonatal care in Southern Province, Zambia.Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestry.Factors influencing women's preferences for subsequent management in the event of incomplete evacuation of the uterus after misoprostol treatment for miscarriage.Induction of labor in women with a uterine scar.Diclofenac/misoprostol during early pregnancy and the risk of miscarriage: a Danish nationwide cohort study.What is the optimal duration of oral misoprostol treatment for cervical ripening?Medical treatment of second-trimester fetal miscarriage; A retrospective analysis.Facilitating women's access to misoprostol through community-based advocacy in Kenya and Tanzania.Implementing evidence-based science to improve women's health globally.A safety review of medications used for labour induction.Labor Induction with Orally Administrated Misoprostol: A Retrospective Cohort Study.Effect of Premature Rupture of Membranes on Induction of Labor: A Historical Cohort Study.Effectiveness and safety of sublingual misoprostol in medical treatment of the 1st trimester miscarriage: experience of off-label use in Korea.Misoprostol vaginal insert versus misoprostol vaginal tablets for the induction of labour: a cohort study.Prevention and Management of Postpartum Haemorrhage
P2860
Q26771528-695FFB73-63A7-49EA-BF95-3DEBF24D5A0EQ28066428-5206AA83-D01C-4A66-A4B1-92A6F11C15F5Q34539890-93FA3329-71F9-4A11-9FA9-C572CE4F7DB3Q34702688-06E26110-BD9D-40A1-B02F-4FE83C663444Q35158202-AAF131AC-7F4E-46DE-BE08-F87A578A14B0Q35839057-91310A2E-6B37-4FD7-BDFF-A8D490A93AB6Q37054405-896546CD-DBA9-446E-9D3D-6E9A8EA74E3AQ37168508-78403F27-8072-47E5-BD55-581547647542Q37210925-11E36074-9EEF-47EF-8B89-58C25B137898Q38225732-B15D71A1-40F7-41DE-A367-4E8593E36C93Q38393664-1B7468B4-58FD-457E-B9F7-32B51A9F3462Q38858861-F1D04DB0-291A-4EF0-A51F-6DA3E77E9320Q39346443-4E69400F-BF5F-4FD9-BB9F-22C8471DDCB9Q40176204-AD006489-D46F-4DD2-9D7D-8F91D9D2377FQ40301239-9182EB54-15D5-4C61-B43E-C0EEB282F4B8Q40635159-256855BC-1254-4BA8-87D4-B3E4011790C3Q42339130-CF378C21-C2F4-4FFE-BE01-6B626DD97846Q43935667-11B5F54E-E2AC-4F4B-BC50-EBF470F7D9F9Q44461642-A6CB2CF2-5D94-4D76-AD01-1B47650243A8Q46227982-717BBFEC-630B-48A2-94C5-CF826A99B6C3Q46868743-950E2D69-3181-444F-A13F-855A427D5FA0Q47104970-DDA7F897-566F-4035-A649-DEE7CB5AC7DBQ55075084-BFA85DEB-4CB9-490E-8BAC-A22F266421F5Q55334360-70EA7205-8CD0-4F08-99B7-D46EF43334F0Q56674877-C9703846-A2F1-4BAB-B9F8-10A14BB93399
P2860
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
@en
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
@nl
type
label
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
@en
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
@nl
prefLabel
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
@en
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
@nl
P2093
P2860
P1476
WHO recommendations for misoprostol use for obstetric and gynecologic indications.
@en
P2093
Jennifer Tang
Joao Paulo de Souza
Nathalie Kapp
P2860
P304
P356
10.1016/J.IJGO.2012.12.009
P577
2013-02-19T00:00:00Z